Cancer and Advantages of Immunosuppression

Volume 1 - Issue 2

Mirta D Ambra*

Received: March 05, 2018;   Published: March 09, 2018

DOI: 10.32474/OAJOM.2018.01.000108

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

As oncologists learn to target the immune response to “self and non-self,” a delicate therapy balance will eventually be achieved with predictable outcomes, benefits, and toxicity in the fightThe study of how the immune system recognizes friend and foe, or as the immunologist Sir Macfarlane Burnet phrased it, “distinguishes between self and non-self,” has driven important discoveries that are transforming our ability to treat cancer.

Abbrevations: NK: Natural Killer; GVHD: Graft-vs-Host Disease; CRS: Cytokine Release Syndrome

Editorial|